Crawford Investment Counsel’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $120M | Buy |
|
|||||
|
2025
Q2 | $108M | Sell |
|
|||||
|
2025
Q1 | $115M | Sell |
|
|||||
|
2024
Q4 | $106M | Buy |
|
|||||
|
2024
Q3 | $120M | Sell |
|
|||||
|
2024
Q2 | $121M | Sell |
|
|||||
|
2024
Q1 | $105M | Buy |
|
|||||
|
2023
Q4 | $102M | Sell |
|
|||||
|
2023
Q3 | $103M | Buy |
|
|||||
|
2023
Q2 | $108M | Sell |
|
|||||
|
2023
Q1 | $108M | Sell |
|
|||||
|
2022
Q4 | $110M | Sell |
|
|||||
|
2022
Q3 | $89.3M | Sell |
|
|||||
|
2022
Q2 | $109M | Sell |
|
|||||
|
2022
Q1 | $116M | Sell |
|
|||||
|
2021
Q4 | $104M | Buy |
|
|||||
|
2021
Q3 | $107M | Buy |
|
|||||
|
2021
Q2 | $107M | Sell |
|
|||||
|
2021
Q1 | $94M | Buy |
|
|||||
|
2020
Q4 | $90.6M | Sell |
|
|||||
|
2020
Q3 | $100M | Buy |
|
|||||
|
2020
Q2 | $96.2M | Sell |
|
|||||
|
2020
Q1 | $85.2M | Buy |
|
|||||
|
2019
Q4 | $91.2M | Buy |
|
|||||
|
2019
Q3 | $71.8M | Sell |
|
|||||
|
2019
Q2 | $67M | Sell |
|
|||||
|
2019
Q1 | $66.5M | Sell |
|
|||||
|
2018
Q4 | $63M | Sell |
|
|||||
|
2018
Q3 | $69M | Buy |
|
|||||
|
2018
Q2 | $60.6M | Buy |
|
|||||
|
2018
Q1 | $56.5M | Buy |
|
|||||
|
2017
Q4 | $20.9M | Buy |
|
|||||
|
2017
Q3 | $20M | Buy |
|
|||||
|
2017
Q2 | $14.8M | Sell |
|
|||||
|
2017
Q1 | $17.3M | Buy |
|
|||||
|
2016
Q4 | $13.7M | Buy |
|
|||||
|
2016
Q3 | $15.5M | Buy |
|
|||||
|
2016
Q2 | $11.6M | Buy |
|
|||||
|
2016
Q1 | $8.49M | Buy |
|
|||||
|
2015
Q4 | $392K | Sell |
|
|||||
|
2015
Q3 | $425K | Buy |
|
|||||
|
2015
Q2 | $398K | Sell |
|
|||||
|
2015
Q1 | $2.77M | Buy |
|
|||||
|
2014
Q4 | $2.8M | Sell |
|
|||||
|
2014
Q3 | $3.04M | Buy |
|
|||||
|
2014
Q2 | $1.76M | Sell |
|
|||||
|
2014
Q1 | $3.43M | Sell |
|
|||||
|
2013
Q4 | $10.2M | Buy |
|
|||||
|
2013
Q3 | $8.68M | Buy |
|
|||||
|
2013
Q2 | $7.64M | Buy |
|